In-vitro and in-vivo assessment of dextran-appended cellulose acetate phthalate nanoparticles for transdermal delivery of 5-fluorouracil

References

• Akimoto T, Nagase Y. (2003). Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group. J Cont Rel 88:243–52
   PubMed Web of Science ®Google Scholar
• Alsarra IA, Alarifi MN. (2004). Validated liquid chromatographic determination of 5-Fluorouracil in human plasma. J Chromatogr B 804:435–39
   PubMed Web of Science ®Google Scholar
• Ansifield FJ, Schroeder JM, Curreri AR. (1962). Five years clinical experience with 5-fluorouracil. J Am Med Assoc 181:295–9
   PubMed Web of Science ®Google Scholar
• Bhadra D, Yadav AK, Bhadra S, Jain NK. (2005). Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Inter J Pharma 295:221–33
   PubMed Web of Science ®Google Scholar
• Campos FdS, Cassimiro DL, Crespi MS, et al. (2013). Preparation and characterisation of dextran-70 hydrogel for controlled release of praziquantel. Braz J Pharm Sci 49:75–83
   Web of Science ®Google Scholar
• Cudd A, Arvinte T, Schulz B, Nicolau C. (1989). Dextran protection of erythrocytes from low-pH-induced hemolysis. FEB 250:293–6
   PubMed Web of Science ®Google Scholar
• Deng W, Li J, Yao P, et al. (2010). Green preparation process, characterization and antitumor effects of doxorubicin–BSA–Dextran nanoparticles. Macromol Biosci 10:1224–34
   PubMed Web of Science ®Google Scholar
• Diasio RB, Harris BE. (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacol 16:215–37
   Google Scholar
• Djordjevic J, Michniak B, Uhrich KE. (2003). Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs. AAPS PharmSci 5:1–12
   Google Scholar
• ElMeshad AN, Tadros MI. (2011). Transdermal delivery of an anti-cancer drug via W/O emulsions based on alkyl polyglycosides and lecithin: design, characterization, and in vivo evaluation of the possible irritation potential in rats. AAPS PharmSciTech 12:1–9
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J Cont Rel 71:53–69
   PubMed Web of Science ®Google Scholar
• Flynn GL. (1996). Cutaneous and transdermal delivery: processes and systems of delivery. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. New York: Marcel Dekker, 187–237
   Google Scholar
• Fukushima S, Kishimoto S, Horai S, et al. (2001). Transdermal drug delivery by electroporation applied on the stratum corneum of rat using stamp-type electrode and frog-type electrode in vitro. Biol Pharm Bull 24:1027–31
   PubMed Web of Science ®Google Scholar
• Ghoshal K, Jacob ST. (1997). An alternative molecular mechanism of action of 5-fluorouracil. A potent anticancer drug. Biochem Pharma 53:1569–75
   PubMed Web of Science ®Google Scholar
• Guy RH. (1996). Current status and future prospects of transdermal drug delivery. Pharm Res 13:1765–8
   PubMed Web of Science ®Google Scholar
• Hadgraft J, Guy RH, eds. (1989). Transdermal drug delivery: development issues and research initiatives. New York: Marcel Dekker
   Google Scholar
• Hao H, Mab Q, Huang C, et al. (2013). Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface. Inter J Pharma 444:77–84
   PubMed Web of Science ®Google Scholar
• Jelvehgari M, Hassanzadeh D, Kiafarar F, et al. (2011). Preparation and determination of drug-polymer interaction and in-vitro release of mefenamic acid microspheres made of cellulose acetate phthalate and/or ethylcellulose polymers. Iranian J Pharma Res 10:457–67
   PubMed Web of Science ®Google Scholar
• Jenning V, Schafer-Korting M, Gohla S. (2000). Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Cont Rel 66:115–26
   PubMed Web of Science ®Google Scholar
• Jeong YI, Choi KC, Song CE. (2006). Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. Arch Pharm Res 29:712–19
   PubMed Web of Science ®Google Scholar
• Kligman AM, Christophers E. (1963). Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702–5
   PubMed Web of Science ®Google Scholar
• Kolhe P, Misra E, Kannan RM, et al. (2003). Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm 259:143
   PubMed Web of Science ®Google Scholar
• Kydonieus A. (1992). Treatise on controlled drug delivery: fundamentals, optimization and applications. New York: Marcel Dekker
   Google Scholar
• Patrick AI, Beall HD, Gilroy P, Sloan KB. (1997). Effect of vehicles on topical delivery of 5-fluorouracil (5-FU) by 1-acyl-5-FU prodrugs. Inter J Pharm 154:39–48
   Web of Science ®Google Scholar
• Potineni A, Lynn MD, Langer R, Amiji MM. (2003). Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery. J Cont Rel 86:223–34
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Fessi H, All'emann E, Doelker E. (1996). Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 143:133–41
   Web of Science ®Google Scholar
• Ranade VV, Hollinger MA, eds. (1996). Drug delivery systems. Boca Raton, FL: CRC Press
   Google Scholar
• Seema, Monika Datta. (2014). Organoclay pluronic F-68 – montmorillonite, as a sustained release drug delivery vehicle for propranolol hydrochloride. Eur Chem Bull 3:593–604
   Google Scholar
• Surber C. (1990). Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm Res 7:1320–4
   PubMed Web of Science ®Google Scholar
• Verma PRP, Chandak AR. (2009). Development of matrix controlled transdermal delivery systems of pentazocine: in vitro/in vivo performance. Acta Pharm 59:171–86
   PubMed Web of Science ®Google Scholar
• Yadav AK, Agarwal A, Jain S, et al. (2010). Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization. J Biomed Nanotech 6:1–11
   PubMed Web of Science ®Google Scholar
• Zalipsky S, Gilon C, Zilkha A. (1983). Attachment of drugs to polyethylene glycols. Eur J Polym 19:1177–83
   Web of Science ®Google Scholar
• Zu Y, Wang D, Zhao X, et al. (2011). A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles. Int J Mol Sci 12:4237–49
   PubMed Web of Science ®Google Scholar